- Home
- LUCD vs IOR Comparison
LUCD vs IOR Comparison
Compare LUCD & IOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- IOR
- Stock Information
- Founded
- LUCD 2018
- IOR 1984
- Country
- LUCD United States
- IOR United States
- Employees
- LUCD 70
- IOR N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IOR Real Estate Investment Trusts
- Sector
- LUCD Health Care
- IOR Real Estate
- Exchange
- LUCD Nasdaq
- IOR Nasdaq
- Market Cap
- LUCD 135.6M
- IOR N/A
- IPO Year
- LUCD 2021
- IOR N/A
- Fundamental
- Price
- LUCD $1.15
- IOR $17.80
- Analyst Decision
- LUCD Strong Buy
- IOR
- Analyst Count
- LUCD 4
- IOR 0
- Target Price
- LUCD $3.88
- IOR N/A
- AVG Volume (30 Days)
- LUCD 1.3M
- IOR 1.9K
- Earning Date
- LUCD 05-14-2025
- IOR 05-20-2025
- Dividend Yield
- LUCD N/A
- IOR N/A
- EPS Growth
- LUCD N/A
- IOR N/A
- EPS
- LUCD N/A
- IOR 1.14
- Revenue
- LUCD $4,346,000.00
- IOR N/A
- Revenue This Year
- LUCD $107.75
- IOR N/A
- Revenue Next Year
- LUCD $231.37
- IOR N/A
- P/E Ratio
- LUCD N/A
- IOR $15.62
- Revenue Growth
- LUCD 79.00
- IOR N/A
- 52 Week Low
- LUCD $0.63
- IOR $15.69
- 52 Week High
- LUCD $1.80
- IOR $19.00
- Technical
- Relative Strength Index (RSI)
- LUCD 41.93
- IOR 52.07
- Support Level
- LUCD $1.19
- IOR $17.01
- Resistance Level
- LUCD $1.24
- IOR $18.69
- Average True Range (ATR)
- LUCD 0.07
- IOR 0.18
- MACD
- LUCD -0.00
- IOR 0.02
- Stochastic Oscillator
- LUCD 15.79
- IOR 47.02
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.